A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...
Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...
A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.
Scalp psoriasis improvement was maintained with long-term tildrakizumab treatment in what researchers said is the first ...
A doctor may prescribe injectable treatments, such as methotrexate, TNF-alpha inhibitors, or interleukin inhibitors, for moderate to severe psoriasis when other treatments don’t work.